Drug Shortage Report for SANDOZ MOMETASONE
Report ID | 74745 |
Drug Identification Number | 02449811 |
Brand name | SANDOZ MOMETASONE |
Common or Proper name | MOMETASONE |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | MOMETASONE FUROATE |
Strength(s) | 50MCG |
Dosage form(s) | SPRAY, METERED DOSE |
Route of administration | NASAL |
Packaging size | 140 |
ATC code | R01AD |
ATC description | DECONGESTANTS AND OTHER NASAL PREP.FOR TOPICAL USE |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-01-21 |
Estimated end date | 2019-02-12 |
Actual end date | 2019-02-11 |
Shortage status | Resolved |
Updated date | 2019-02-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2019-02-18 | French | Compare |
v9 | 2019-02-18 | English | Compare |
v8 | 2019-02-12 | French | Compare |
v7 | 2019-02-12 | English | Compare |
v6 | 2019-02-12 | French | Compare |
v5 | 2019-02-12 | English | Compare |
v4 | 2019-02-06 | French | Compare |
v3 | 2019-02-06 | English | Compare |
v2 | 2019-02-04 | French | Compare |
v1 | 2019-02-04 | English | Compare |
Showing 1 to 10 of 10